Business · 08/12/2017Updated: 10/17/2026 · 1 min read
FDA Publishes Annual Report on Postmarketing Requirements and Commitments for Drug and Biologics Firms
Summary
The FDA has released its annual report on postmarketing requirements and commitments for drug and biologics firms, as mandated by the Federal Food, Drug, and Cosmetic Act, detailing the status of studies and clinical trials required or agreed upon by approved product holders.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →